anmelden
Novartis Aktie
128,14
EUR
-0,16
EUR
-0,12
%
128,16
EUR
-0,82
EUR
-0,64
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 22.07.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.07.20 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.20 | Novartis Hold | Kepler Cheuvreux | |
| 21.07.20 | Novartis Neutral | UBS AG | |
| 21.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis buy | Jefferies & Company Inc. | |
| 21.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 16.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.06.20 | Novartis Neutral | UBS AG | |
| 22.06.20 | Novartis buy | Oddo BHF | |
| 10.06.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.06.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.05.20 | Novartis Neutral | UBS AG | |
| 11.05.20 | Novartis Neutral | UBS AG | |
| 08.05.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.05.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.20 | Novartis Hold | HSBC | |
| 29.04.20 | Novartis Neutral | Credit Suisse Group | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis Neutral | UBS AG | |
| 28.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.04.20 | Novartis Hold | Deutsche Bank AG | |
| 02.04.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 01.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 31.03.20 | Novartis buy | Oddo BHF | |
| 24.03.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.03.20 | Novartis Hold | Deutsche Bank AG | |
| 17.03.20 | Novartis Underweight | Barclays Capital | |
| 11.03.20 | Novartis Equal-Weight | Morgan Stanley | |
| 26.02.20 | Novartis Hold | Deutsche Bank AG | |
| 25.02.20 | Novartis Underweight | Barclays Capital | |
| 25.02.20 | Novartis buy | Jefferies & Company Inc. | |
| 25.02.20 | Novartis Neutral | UBS AG | |
| 31.01.20 | Novartis Hold | Deutsche Bank AG | |
| 30.01.20 | Novartis Neutral | Credit Suisse Group | |
| 30.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novartis Neutral | UBS AG | |
| 29.01.20 | Novartis Hold | Kepler Cheuvreux | |
| 29.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
Werbung
Werbung